DABIGATRAN 150 mg/1
DABIGATRAN ETEXILATE · CAPSULE · AvPAK
No Recall History
Plain English
DABIGATRAN is a capsule containing dabigatran etexilate at 150 mg/1, taken oral. Manufactured by AvPAK.
Key Facts
- Brand Name
- DABIGATRAN
- Generic Name
- DABIGATRAN ETEXILATE
- NDC Code (Product)
50268-200- Manufacturer
- AvPAK
- Strength
- 150 mg/1
- Dosage Form
- CAPSULE
- Route
- ORAL
- Marketing Status
- Application #
- ANDA213879
- Marketing Start
- 07/12/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is DABIGATRAN used for?
DABIGATRAN contains DABIGATRAN ETEXILATE. It is a capsule taken oral. Consult your doctor for specific uses.
Is DABIGATRAN a controlled substance?
DABIGATRAN is not classified as a controlled substance by the DEA.
What is the generic name for DABIGATRAN?
The generic name for DABIGATRAN is DABIGATRAN ETEXILATE. There are 10 other brand versions of DABIGATRAN ETEXILATE.
What is the NDC code for DABIGATRAN 150 mg/1?
The NDC (National Drug Code) for DABIGATRAN 150 mg/1 is 50268-200, listed by AvPAK.
Other DABIGATRAN Dosages
Other Dabigatran Brands
See all →- Pradaxa20 mg/10597-0425
- DABIGATRAN ETEXILATE150 mg/159651-975
- Dabigatran Etexilate150 mg/131722-622
- Dabigatran etexilate150 mg/143598-641
- Dabigatran Etexilate75 mg/146708-634
- DABIGATRAN ETEXILATE110 mg/159651-974
- dabigatran etexilate150 mg/160505-4348
- Dabigatran Etexilate75 mg/162332-634
- Dabigatran Etexilate150 mg/10378-0266
- Pradaxa150 mg/10597-0360
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)